Paller Channing J, Shiels Meredith S, Rohrmann Sabine, Basaria Shehzad, Rifai Nader, Nelson William, Platz Elizabeth A, Dobs Adrian
Department of Endocrinology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
Clin Endocrinol (Oxf). 2009 Jan;70(1):26-34. doi: 10.1111/j.1365-2265.2008.03300.x. Epub 2008 May 14.
Sex steroid hormones influence bone mineral density (BMD) in women, but are less well-studied in men. We evaluated the association of serum total and free sex steroid hormones and SHBG with osteopaenia in a nationally representative sample of men aged 20-90 years.
BMD and sex steroid hormones were measured among participants in NHANES III, a cross-sectional study of the US population.
A total of 1185 adult men in morning examination session of Phase I of NHANES III (1988-91).
Relation of oestradiol (E(2)), testosterone, and SHBG concentrations with BMD. Osteopaenia was defined as 1-2.5 SD below the mean for white men aged 20-29 years.
Men in the lowest quartile of free E(2) had 70% increased odds (OR = 1.69, 95% CI 0.95-2.98) of osteopaenia compared with men in the highest quartile. Men in the lowest quartile of free testosterone had nearly four times the odds of osteopaenia than those in the highest quartile (OR = 3.82, 95% CI 1.87-7.78). Lower concentrations of SHBG appeared protective against osteopaenia (P-trend = 0.01). Neither total testosterone nor total E(2) was associated with BMD, although men with clinically low E(2) (< 20 ng/l) had lower BMD (0.930 g/cm(2), 95% CI 0.88-0.98) than men with normal-range E(2) (1.024 g/cm(2), 95% CI 1.01-1.04; P = 0.004). Findings for free E(2) were most pronounced among elderly men, while the findings for free testosterone were most pronounced among younger men.
In this nationally representative study, men with lower free E(2), lower free testosterone, and higher SHBG concentrations in circulation were more likely to have low BMD.
性类固醇激素会影响女性的骨密度(BMD),但在男性中的研究较少。我们在一个具有全国代表性的20 - 90岁男性样本中,评估了血清总性类固醇激素、游离性类固醇激素和性激素结合球蛋白(SHBG)与骨质减少的关联。
在美国人群横断面研究NHANES III的参与者中测量骨密度和性类固醇激素。
NHANES III第一阶段(1988 - 1991年)上午检查时段的1185名成年男性。
雌二醇(E₂)、睾酮和SHBG浓度与骨密度的关系。骨质减少定义为比20 - 29岁白人男性的平均值低1 - 2.5个标准差。
游离E₂处于最低四分位数的男性与处于最高四分位数的男性相比,骨质减少的几率增加了70%(OR = 1.69,95%CI 0.95 - 2.98)。游离睾酮处于最低四分位数的男性骨质减少的几率几乎是最高四分位数男性的四倍(OR = 3.82,95%CI 1.87 - 7.78)。较低的SHBG浓度似乎对骨质减少有保护作用(趋势P值 = 0.01)。总睾酮和总E₂均与骨密度无关,尽管临床E₂水平低(< 20 ng/l)的男性骨密度(0.930 g/cm²,95%CI 0.88 - 0.98)低于E₂在正常范围的男性(1.024 g/cm²,95%CI 1.01 - 1.04;P = 0.004)。游离E₂的研究结果在老年男性中最为明显,而游离睾酮的研究结果在年轻男性中最为明显。
在这项具有全国代表性的研究中,循环中游离E₂较低、游离睾酮较低且SHBG浓度较高的男性更有可能骨密度较低。